What’s Going on in Finance Today
The European Central Bank (ECB) may need to take additional stimulus steps as inflation hit only 0.1% in October, far lower than the bank’s 2% expectation. The ECB has options, which the bank will discuss come December. They include improving their quantitative easing program which injects money into the economy, resulting in a depression of interest rates. They also have the option of pushing their deposit rate further into negative territory. Find out what the ECB has to look forward to in the coming months with this article.
Jawbone, a wearable devices competitor of Apple and Fitbit, is closing its New York offices and laying off 60 employees. Jawbone has however increased focus on its R&D and marketing departments. They hope to streamline a more successful company, according to a Jawbone spokesman. See what’s next for Jawbone here.
CFO.com offers the insights and information finance professionals won’t find anywhere else on the web. Enjoy today’s CFO roundup.
CFOs on the Move: Week Ending Nov. 20
Louis Berger, Manitowoc, Hertz Equipment Rental, Rogers, Pegasystems, Goodrich Petroleum, Adtran, Syntel, Quaker Chemical, Schweitzer Mauduit
Towers Watson, Willis Sweeten Merger Terms
To get Towers Watson shareholders to approve the deal, the companies raise the special cash dividend to $10 a share.
Why CFOs Need to Pay Attention to Blockchain Technology
The ‘blockchain’ allows for a scalable and secure ledger with unlimited account creation and programmable, trackable money.
European Central Bank May Expand Stimulus
The bank could step up its $1 trillion bond buying program with inflation still stubbornly below its 2% target.
Jawbone Laying Off 15% of Workforce
The wearable devices maker has been facing stiff competition in a fitness tracker market dominated by Fitbit and Xiaomi.
House Passes ‘Audit The Fed’ Bill
The White House has threatened a veto of the FORM Act, saying it would compromise the Federal Reserve’s independence.
Novartis Settles Kickback Charges for $370M
The Swiss drug maker allegedly turned specialty pharmacies into a “biased sales force” for its medications.
Get the best financial whitepapers, ebooks and webcasts in the CFO whitepaper library.
